-
921
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
Published 2021-03-01“…Ovarian cancer treatment strategy is mainly based on three pillars: cytoreductive surgery, platinum-based chemotherapy, and targeted therapies. …”
Get full text
Article -
922
-
923
-
924
Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Published 2019-08-01Get full text
Article -
925
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Published 2022-03-01Get full text
Article -
926
Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications
Published 2020-02-01Subjects: Get full text
Article -
927
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Published 2022-04-01“…Although the scientific community has been concerned about guaranteeing the quality of life of cancer patients, researchers are also aware of the increasing costs related to cancer treatment, and efforts have been made to find alternatives to the development of new drugs. …”
Get full text
Article -
928
Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment
Published 2022-11-01“…In this review, the data available on nanomaterials of group XIV for breast cancer treatment has been documented, providing a useful insight into tumor biology and nano–bio interactions to develop more effective nanotherapeutics for cancer patients.…”
Get full text
Article -
929
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
Published 2022-05-01“…Autophagy represents a promising but challenging target in cancer treatment. Green tea is a widely used beverage with healthy effects on several diseases, including cancer. …”
Get full text
Article -
930
Corrigendum: Landscape of pediatric cancer treatment refusal and abandonment in the US: a qualitative study
Published 2024-02-01Get full text
Article -
931
A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment
Published 2020-02-01Get full text
Article -
932
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
Published 2021-07-01“…In this review, we discuss the impact of these two analogues on cancerous processes but also their potential for cancer treatment alone or in combination with existing approaches.…”
Get full text
Article -
933
-
934
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
Published 2023-08-01“…CUB domain‐containing protein 1 (CDCP1) contributes to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance by regulating EGFR signaling pathways and is a potential target in lung cancer treatment. This study aims to identify a CDCP1 reducer that synergistically improves TKI treatment. …”
Get full text
Article -
935
Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023
Published 2023-12-01Get full text
Article -
936
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
Published 2023-10-01Subjects: Get full text
Article -
937
Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment
Published 2023-01-01Get full text
Article -
938
A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment
Published 2023-02-01Get full text
Article -
939
Potential of <i>Kalanchoe pinnata</i> as a Cancer Treatment Adjuvant and an Epigenetic Regulator
Published 2022-09-01“…All of the data support the use of <i>K. pinnata</i> as an adjuvant in cancer treatment.…”
Get full text
Article -
940